Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?
Voorrips SN, Saucedo-Orozco H, Sánchez-Aguilera PI, De Boer RA, Van der Meer P, Westenbrink BD. Voorrips SN, et al. Among authors: van der meer p. Int J Mol Sci. 2022 Aug 3;23(15):8631. doi: 10.3390/ijms23158631. Int J Mol Sci. 2022. PMID: 35955784 Free PMC article. Review.
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH. van der Meer P, et al. Among authors: van de wal rm, van gilst wh, van veldhuisen dj. Circulation. 2005 Sep 20;112(12):1743-7. doi: 10.1161/CIRCULATIONAHA.105.549121. Circulation. 2005. PMID: 16172283
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
Lipsic E, van der Meer P, Voors AA, Westenbrink BD, van den Heuvel AF, de Boer HC, van Zonneveld AJ, Schoemaker RG, van Gilst WH, Zijlstra F, van Veldhuisen DJ. Lipsic E, et al. Among authors: van gilst wh, van den heuvel af, van der meer p, van zonneveld aj, van veldhuisen dj. Cardiovasc Drugs Ther. 2006 Apr;20(2):135-41. doi: 10.1007/s10557-006-7680-5. Cardiovasc Drugs Ther. 2006. PMID: 16761193 Clinical Trial.
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Westenbrink BD, et al. Among authors: van gilst wh, van der harst p, van der meer p, van veldhuisen dj. Eur Heart J. 2007 Aug;28(16):2018-27. doi: 10.1093/eurheartj/ehm177. Epub 2007 Jun 17. Eur Heart J. 2007. PMID: 17576662
Anemia and erythropoietin in heart failure.
van der Meer P, Lipsic E, van Gilst WH, van Veldhuisen DJ. van der Meer P, et al. Among authors: van gilst wh, van veldhuisen dj. Heart Fail Monit. 2008;6(1):28-33. Heart Fail Monit. 2008. PMID: 18607519
Anaemia and renal dysfunction in chronic heart failure.
van der Meer P, van Veldhuisen DJ. van der Meer P, et al. Among authors: van veldhuisen dj. Heart. 2009 Nov;95(21):1808-12. doi: 10.1136/hrt.2008.151258. Heart. 2009. PMID: 19828825 No abstract available.
Stem cells in heart failure.
Domian IJ, Buikema JW, de Boer RA, van der Meer P. Domian IJ, et al. Among authors: van der meer p. Eur J Heart Fail. 2010 Jul;12(7):642-4. doi: 10.1093/eurjhf/hfq105. Eur J Heart Fail. 2010. PMID: 20576832 Free article. No abstract available.
608 results